MYOCARDIAL INJURY
Clinical trials for MYOCARDIAL INJURY explained in plain language.
Never miss a new study
Get alerted when new MYOCARDIAL INJURY trials appear
Sign up with your email to follow new studies for MYOCARDIAL INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for heart attack survivors with no blocked arteries?
Disease control Recruiting nowThis study tests a drug called eplerenone in people who had a heart attack or heart injury but no blocked arteries. It focuses on those with tiny blood vessel problems. About 400 participants will be split into groups: some get usual care, others get eplerenone. The goal is to se…
Matched conditions: MYOCARDIAL INJURY
Phase: PHASE2 • Sponsor: NHS National Waiting Times Centre Board • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Race against time: can quicker hip surgery save lives after a heart attack?
Disease control Recruiting nowThis study looks at whether doing hip fracture surgery sooner (within hours) can lower the chance of death within 90 days for patients who also have a recent heart injury. About 1100 adults aged 45 and older with a hip fracture and elevated troponin (a sign of heart damage) will …
Matched conditions: MYOCARDIAL INJURY
Phase: NA • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New sedative may shield heart during lung surgery
Disease control Recruiting nowThis study tests whether a newer sedative called ciprofol can reduce heart damage after lung surgery compared to the standard drug propofol. About 1,058 adults aged 45–80 having keyhole lung surgery will be randomly assigned to receive one of the two drugs. The main goal is to se…
Matched conditions: MYOCARDIAL INJURY
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Could a single shot before surgery shield your heart?
Prevention Recruiting nowThis study tests whether a single injection of a GLP-1 receptor agonist (a type of diabetes drug) given 1 to 14 days before planned non-cardiac surgery can reduce heart muscle injury. 372 adults having intermediate- to high-risk surgery will be randomly assigned to receive the dr…
Matched conditions: MYOCARDIAL INJURY
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated May 13, 2026 15:58 UTC